Cash And Equivalent تغيير تاريخ
AbbVie USD 13.29B 4.53B 2023-09
Acorda Therapeutics USD 25.27M 4.98M 2023-06
Amgen USD 10.94B 23.8B 2023-12
Arrowhead Research USD 58.22M 44.78M 2023-12
AstraZeneca USD 4.87B 793M 2023-09
BioCryst Pharmaceuticals USD 397.59M 251.38M 2023-09
Biogen USD 1.05B 1.24B 2023-12
Bristol-Myers Squibb USD 11.46B 3.95B 2023-12
Enanta Pharmaceuticals USD 85.39M 9.79M 2023-09
Gilead Sciences USD 8.43B 2.72B 2023-12
GlaxoSmithKline GBP 3.18B 37M 2023-09
Halozyme Therapeutics USD 118.37M 155.86M 2023-12
Heron Therapeutics USD 34.86M 21.4M 2023-09
Immunic USD 59.69M 17.6M 2023-09
Incyte USD 3.21B 13.85M 2023-12
Insmed USD 482.37M 4.74M 2023-12
Ionis Pharmaceuticals USD 399.27M 47.21M 2023-12
J&J USD 3.5B 497M 2023-09
Ligand Pharmaceuticals USD 22.95M 3.68M 2023-12
Marinus Pharmaceuticals USD 140.44M 12.65M 2023-09
Merck USD 8.6B 2.94B 2023-09
Neurocrine Biosciences USD 293.7M 133.5M 2023-09
Novavax USD 651.1M 145.19M 2023-09
Pfizer USD 3.15B 516M 2023-09
PTC Therapeutics USD 594M 428.84M 2023-12
Roche Holding CHF 3.72B 1.27B 2023-06
Sarepta Therapeutics USD 541.93M 310M 2023-09
Vertex Pharmaceuticals USD 11.11B 959.1M 2023-09



Enanta Pharmaceuticals النقدية وما يعادلها - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - Mar 2024.